Endocyte Inc (ECYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Sales | 70 | 70 | 70 | 70,354 | 64,871 |
| Gross Profit | 70 | 70 | 70 | 70,354 | 64,871 |
| Operating Expenses | 56,176 | 44,790 | 42,043 | 65,327 | 83,213 |
| Operating Income | -56,106 | -44,720 | -41,973 | 5,027 | -18,342 |
| Other Income | 1,042 | 833 | 703 | 433 | 309 |
| Pre-tax Income | -55,064 | -43,888 | -41,270 | 5,460 | -18,032 |
| Net Income Continuous | -55,064 | -43,888 | -41,270 | 5,460 | -18,032 |
| Net Income | $-55,064 | $-43,888 | $-41,270 | $5,460 | $-18,032 |
| EPS Basic Total Ops | -1.25 | -1.04 | -0.98 | 0.14 | -0.50 |
| EPS Basic Continuous Ops | -1.25 | -1.04 | -0.98 | 0.14 | -0.50 |
| EPS Diluted Total Ops | -1.25 | -1.04 | -0.98 | 0.13 | -0.50 |
| EPS Diluted Continuous Ops | -1.25 | -1.04 | -0.98 | 0.13 | -0.50 |
| EPS Diluted Before Non-Recurring Items | -1.00 | -1.04 | -0.98 | 0.13 | -0.37 |
| EBITDA(a) | $-55,345 | $-43,405 | $-39,776 | $7,499 | $-16,421 |